AL AMYLOIDOSIS
Clinical trials for AL AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AL AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AL AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for Tough-to-Treat blood disorder
Disease control CompletedThis study tested an experimental drug called belantamab mafodotin in 35 adults whose AL amyloidosis had returned or stopped responding to previous treatments. AL amyloidosis is a serious condition where abnormal proteins build up and damage organs like the heart and kidneys. The…
Matched conditions: AL AMYLOIDOSIS
Phase: PHASE2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
One donor, two transplants: experimental procedure aims to cure blood cancer and fix kidneys
Disease control CompletedThis pilot study tested a combined transplant from a partially matched family donor. It aimed to treat patients who had both a serious blood disorder (like leukemia) and advanced kidney disease at the same time. The goal was to cure the blood disorder and restore kidney function …
Matched conditions: AL AMYLOIDOSIS
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Scientists hunt for early warning signs of a silent killer
Knowledge-focused CompletedThis study aimed to understand how a serious inherited disease called hereditary transthyretin amyloidosis begins. Researchers followed 37 people who carry the disease gene but had no symptoms, tracking a specific protein in their blood over five years. The goal was to see if thi…
Matched conditions: AL AMYLOIDOSIS
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC